
Week 6: Regulatory Shifts, Tariff Action & Industry Feedback
USTR proposes new China tariffs; FDA, CMS, and White House actions could reshape MedTech—member input needed by June 10.
Stay ahead of policy changes with timely, easy-to-digest updates.
AdvaMed’s Weekly Rapid Response Updates deliver concise insights on emerging policy developments, including executive orders, tariffs, and other fast-moving issues impacting our industry. Designed to keep your team aligned and informed, these updates help you respond with confidence.
Stay connected. Stay prepared.
USTR proposes new China tariffs; FDA, CMS, and White House actions could reshape MedTech—member input needed by June 10.
White House tariff actions, DOJ and CMS RFIs, and USTR investigations headline Week 5—member feedback needed this month.
Scott Whitaker’s Senate testimony, drug pricing EO, and updates on key RFIs drive this week’s momentum for MedTech advocacy.
Domestic manufacturing EO, federal reforms, and critical RFIs signal changes for MedTech—member input still welcome.
No FDA overhaul, new federal procurement EOs, and a major court case could shift preventive care coverage requirements.
FDA reorg, port fees, and policy shifts top this week’s update—plus, help shape future AdvaMed rapid response priorities.